Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association
Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition that is
believed to affect> 25% of adults worldwide. Unless specific testing is done to identify …
believed to affect> 25% of adults worldwide. Unless specific testing is done to identify …
NAFLD and cardiovascular diseases: a clinical review
P Kasper, A Martin, S Lang, F Kuetting… - Clinical research in …, 2021 - Springer
Non-alcoholic fatty liver DISEASE (NAFLD) is the most common chronic liver disease in
Western countries and affects approximately 25% of the adult population. Since NAFLD is …
Western countries and affects approximately 25% of the adult population. Since NAFLD is …
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …
disease and affects nearly a quarter of the global population. The objective of this work was …
the epidemiologic burden of non‐alcoholic fatty liver disease across the world
L Henry, J Paik, ZM Younossi - Alimentary pharmacology & …, 2022 - Wiley Online Library
Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
Aims To conduct a systematic literature review to identify recent epidemiological, biomarker,
genetic and clinical evidence that expands our understanding of nonalcoholic fatty liver …
genetic and clinical evidence that expands our understanding of nonalcoholic fatty liver …
The relationship between type 2 diabetes, NAFLD, and cardiovascular risk
C Caussy, A Aubin, R Loomba - Current diabetes reports, 2021 - Springer
Abstract Purpose of Review Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
mellitus (T2DM) are strongly associated. Both also associate with an increased risk of …
mellitus (T2DM) are strongly associated. Both also associate with an increased risk of …
Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development
P Vancells Lujan, E Vinas Esmel… - Nutrients, 2021 - mdpi.com
NAFLD is the world's most common chronic liver disease, and its increasing prevalence
parallels the global rise in diabetes and obesity. It is characterised by fat accumulation in the …
parallels the global rise in diabetes and obesity. It is characterised by fat accumulation in the …
Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors
The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising. NAFLD/nonalcoholic
steatohepatitis (NASH) is associated not only with hepatic morbidity and mortality but also …
steatohepatitis (NASH) is associated not only with hepatic morbidity and mortality but also …
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Background and aim Non-alcoholic fatty liver disease (NAFLD), affecting up to around 30%
of the world's adult population, causes considerable liver-related and extrahepatic morbidity …
of the world's adult population, causes considerable liver-related and extrahepatic morbidity …
Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach
K Drożdż, K Nabrdalik, H Kwiendacz, M Hendel… - Cardiovascular …, 2022 - Springer
Background Nonalcoholic fatty liver disease is associated with an increased cardiovascular
disease (CVD) risk, although the exact mechanism (s) are less clear. Moreover, the …
disease (CVD) risk, although the exact mechanism (s) are less clear. Moreover, the …